214.57
price up icon0.53%   0.92
 
loading
Schlusskurs vom Vortag:
$213.65
Offen:
$214.44
24-Stunden-Volumen:
950.87K
Relative Volume:
0.81
Marktkapitalisierung:
$29.49B
Einnahmen:
$1.96B
Nettoeinkommen (Verlust:
$-253.24M
KGV:
-112.86
EPS:
-1.9012
Netto-Cashflow:
$94.06M
1W Leistung:
+2.53%
1M Leistung:
+18.22%
6M Leistung:
+40.14%
1J Leistung:
+32.50%
1-Tages-Spanne:
Value
$212.33
$219.94
1-Wochen-Bereich:
Value
$195.14
$219.94
52-Wochen-Spanne:
Value
$125.38
$219.94

Natera Inc Stock (NTRA) Company Profile

Name
Firmenname
Natera Inc
Name
Telefon
650-249-9090
Name
Adresse
13011 MCCALLEN PASS, AUSTIN, CA
Name
Mitarbeiter
4,434
Name
Twitter
@nateragenetics
Name
Nächster Verdiensttermin
2024-11-12
Name
Neueste SEC-Einreichungen
Name
NTRA's Discussions on Twitter

Vergleichen Sie NTRA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Diagnostics & Research icon
NTRA
Natera Inc
214.57 29.49B 1.96B -253.24M 94.06M -1.9012
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
571.25 216.42B 43.74B 6.58B 6.11B 17.31
Diagnostics & Research icon
A
Agilent Technologies Inc
144.26 40.78B 6.79B 1.22B 1.09B 4.2644
Diagnostics & Research icon
DHR
Danaher Corp
221.49 159.29B 24.27B 3.50B 5.02B 4.8589
Diagnostics & Research icon
MTD
Mettler Toledo International Inc
1,395.01 28.53B 3.87B 829.75M 847.84M 39.48
Diagnostics & Research icon
WAT
Waters Corp
374.60 22.42B 2.91B 622.64M 620.14M 10.48

Natera Inc Stock (NTRA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-10-27 Hochstufung BNP Paribas Exane Underperform → Neutral
2025-09-22 Fortgesetzt Wells Fargo Equal Weight
2025-03-13 Eingeleitet RBC Capital Mkts Outperform
2025-01-23 Eingeleitet Barclays Overweight
2024-06-03 Fortgesetzt Jefferies Buy
2024-04-08 Fortgesetzt Craig Hallum Buy
2024-02-20 Herabstufung Raymond James Strong Buy → Outperform
2023-12-29 Bestätigt BTIG Research Buy
2023-12-14 Eingeleitet Guggenheim Buy
2023-12-13 Eingeleitet Wolfe Research Outperform
2023-11-13 Hochstufung Raymond James Outperform → Strong Buy
2023-09-28 Eingeleitet Bernstein Mkt Perform
2023-07-05 Fortgesetzt JP Morgan Overweight
2023-05-05 Eingeleitet UBS Buy
2023-01-18 Hochstufung Raymond James Mkt Perform → Outperform
2022-08-25 Eingeleitet Credit Suisse Outperform
2022-04-25 Eingeleitet Stephens Overweight
2022-03-08 Eingeleitet Goldman Buy
2022-01-06 Fortgesetzt Piper Sandler Overweight
2021-10-15 Fortgesetzt Cowen Outperform
2021-06-15 Eingeleitet Raymond James Mkt Perform
2021-05-25 Eingeleitet Wells Fargo Overweight
2021-01-28 Eingeleitet Truist Buy
2020-10-08 Eingeleitet BTIG Research Buy
2020-09-28 Eingeleitet Morgan Stanley Overweight
2020-09-17 Eingeleitet SVB Leerink Outperform
2020-06-10 Fortgesetzt Piper Sandler Overweight
2020-05-07 Hochstufung JP Morgan Neutral → Overweight
2018-10-05 Eingeleitet JP Morgan Neutral
2018-07-05 Bestätigt Piper Jaffray Overweight
2017-08-07 Bestätigt Morgan Stanley Overweight
2016-11-10 Bestätigt The Benchmark Company Buy
2016-05-23 Bestätigt The Benchmark Company Buy
2016-05-11 Bestätigt The Benchmark Company Buy
2016-04-19 Eingeleitet The Benchmark Company Buy
2015-09-28 Hochstufung Wedbush Neutral → Outperform
2015-08-14 Hochstufung Morgan Stanley Equal-Weight → Overweight
2015-08-04 Eingeleitet Robert W. Baird Outperform
2015-07-27 Eingeleitet Morgan Stanley Equal-Weight
2015-07-27 Eingeleitet Piper Jaffray Overweight
2015-07-27 Eingeleitet Wedbush Neutral
Alle ansehen

Natera Inc Aktie (NTRA) Neueste Nachrichten

pulisher
08:33 AM

How Investors May Respond To Natera (NTRA) Oncology Test Integration With Flatiron and Upbeat Guidance - simplywall.st

08:33 AM
pulisher
08:00 AM

Natera (NASDAQ: NTRA) Volunteers Top 28,500 Hours, Surpassing 2025 Service Goal - Stock Titan

08:00 AM
pulisher
07:27 AM

Is Natera Inc. stock positioned for digital transformationMarket Risk Analysis & Accurate Entry and Exit Point Alerts - newser.com

07:27 AM
pulisher
04:36 AM

Is Natera Inc. stock a defensive play in 2025Weekly Profit Summary & Verified Entry Point Signals - newser.com

04:36 AM
pulisher
02:09 AM

Will Natera Inc. stock attract ESG investorsJuly 2025 Price Swings & Weekly Breakout Stock Alerts - newser.com

02:09 AM
pulisher
Nov 18, 2025

Can Natera Inc. stock withstand economic slowdownEarnings Overview Summary & Momentum Based Trading Signals - newser.com

Nov 18, 2025
pulisher
Nov 18, 2025

Avoiding Lag: Real-Time Signals in (NTRA) Movement - news.stocktradersdaily.com

Nov 18, 2025
pulisher
Nov 18, 2025

Can momentum traders help lift Natera Inc.2025 Historical Comparison & Risk Controlled Daily Plans - newser.com

Nov 18, 2025
pulisher
Nov 18, 2025

UBS Raises Natera (NTRA) Price Target to $280, Maintains Buy Rat - GuruFocus

Nov 18, 2025
pulisher
Nov 18, 2025

Natera stock hits all-time high of 212.23 USD By Investing.com - Investing.com South Africa

Nov 18, 2025
pulisher
Nov 18, 2025

UBS Adjusts Natera Price Target to $280 From $218, Maintains Buy Rating - MarketScreener

Nov 18, 2025
pulisher
Nov 18, 2025

TD Cowen Lifts Natera (NTRA) Target to $240, Reiterates Buy Rating - Insider Monkey

Nov 18, 2025
pulisher
Nov 18, 2025

How Natera Inc. stock reacts to bond yieldsQuarterly Portfolio Summary & Reliable Intraday Trade Plans - newser.com

Nov 18, 2025
pulisher
Nov 17, 2025

Natera Shares Surge on Upbeat Forecast and Strategic Expansion - AD HOC NEWS

Nov 17, 2025
pulisher
Nov 16, 2025

Is Natera Inc. stock entering bullish territoryWeekly Profit Recap & Consistent Growth Equity Picks - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

Automated trading signals detected on Natera Inc.July 2025 Fed Impact & Advanced Technical Signal Analysis - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

Natera (NTRA): Valuation Insights Following Raised 2025 Outlook and Strong Quarterly Performance - simplywall.st

Nov 16, 2025
pulisher
Nov 15, 2025

How to integrate Natera Inc. into portfolio analysis toolsAnalyst Upgrade & Accurate Intraday Trade Tips - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

Will Natera Inc. stock beat EPS estimates2025 Institutional Moves & Long Hold Capital Preservation Plans - newser.com

Nov 15, 2025
pulisher
Nov 14, 2025

Ranking Natera Inc. among high performing stocks via toolsProfit Target & Fast Moving Trade Plans - newser.com

Nov 14, 2025
pulisher
Nov 14, 2025

How high can Natera Inc. stock go2025 Market Overview & Risk Managed Trade Strategies - newser.com

Nov 14, 2025
pulisher
Nov 14, 2025

Does Natera (NTRA) Have a Long Runway For Growth? - Insider Monkey

Nov 14, 2025
pulisher
Nov 14, 2025

Stephens Reaffirms Their Buy Rating on Natera (NTRA) - The Globe and Mail

Nov 14, 2025
pulisher
Nov 14, 2025

Natera co-founder Sheena Jonathan sells $903k in stock By Investing.com - Investing.com South Africa

Nov 14, 2025
pulisher
Nov 13, 2025

Published on: 2025-11-05 02:57:17 - newser.com

Nov 13, 2025
pulisher
Nov 13, 2025

Natera price target raised to $235 from $17 at Stephens - TipRanks

Nov 13, 2025
pulisher
Nov 13, 2025

NTRA: Stephens & Co. Raises Price Target on Natera to $235 | NTR - GuruFocus

Nov 13, 2025
pulisher
Nov 13, 2025

Natera stock price target raised to $235 from $197 at Stephens - Investing.com

Nov 13, 2025
pulisher
Nov 13, 2025

Natera Integrates with Flatiron Health’s OncoEMR® Platform - BioSpace

Nov 13, 2025
pulisher
Nov 12, 2025

Natera at UBS Global Healthcare Conference: Strategic Growth and Future Prospects - Investing.com Nigeria

Nov 12, 2025
pulisher
Nov 12, 2025

Natera co-founder Sheena Jonathan sells $903k in stock - Investing.com India

Nov 12, 2025

Finanzdaten der Natera Inc-Aktie (NTRA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Natera Inc-Aktie (NTRA) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Sheena Jonathan
CO-FOUNDER
Nov 11 '25
Sale
207.96
1,500
311,934
25,282
Rabinowitz Matthew
EXECUTIVE CHAIRMAN
Nov 04 '25
Sale
200.51
22,900
4,591,674
2,280,852
Sheena Jonathan
CO-FOUNDER
Nov 03 '25
Sale
200.07
4,000
800,274
26,032
Moshkevich Solomon
PRESIDENT, CLINICALDIAGNOSTICS
Nov 03 '25
Sale
198.60
3,000
595,810
112,061
Marcus Gail Boxer
Director
Nov 03 '25
Sale
198.71
122
24,243
5,762
diagnostics_research IQV
$216.34
price down icon 0.41%
$686.15
price up icon 2.47%
diagnostics_research LH
$258.73
price down icon 0.50%
diagnostics_research DGX
$185.56
price up icon 0.13%
diagnostics_research WAT
$373.61
price down icon 0.64%
Kapitalisierung:     |  Volumen (24h):